DPC 602
Latest Information Update: 15 Jan 2008
Price :
$50 *
At a glance
- Originator Bristol-Myers Squibb
- Class Antithrombotics; Small molecules
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis